US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,792.38

+0.48520.03%

Number of Gainers:7

Number of Losers:11

Number of Flat:1

PE:- -

High:1,810.88

Open:1,791.54

Low:1,783.73

Close:1,791.89

Volume:88.62M

Turnover:4.62B

Market Cap:1.46T

Float Cap:1.44T

Loading ...

Co-Diagnostics Q4 EPS $(16.65) Down From $(10.82) YoY, Sales $263.922K Up From $149.325K YoY

Press Release: Co-Diagnostics Reports Full Year 2025 Financial Results

Pomerantz files securities class action against Lakeland Industries, executives in New York court

Option traders moderately bearish in Moderna with shares up 3.7%

Pfizer Inc Stock (PFE) Moved Up by 3.06% on Mar 31: Facts Behind the Movement

Bearish on Pfizer (PFE) as Big Dividend Fails to Mask the Growth Problem

Gilead Sciences Inc Stock (GILD) Moved Up by 3.62% on Mar 31: A Full Analysis

AstraZeneca Seen as Leader of Next Generation of Biologic Medicines -- Market Talk

Pfizer Submits Migraine Prevention Drug for Approval in China

Galapagos Strikes New Gilead Deal to Co-Develop Gamgertamig and Unlock $500 Million for Strategic Moves

3SBio Announces 2025 Annual Results: Dual Engines of Innovative R&D and Global Collaboration Propel Revenue Past RMB 10 Billion Milestone

AstraZeneca (AZN) Gets a Buy from J.P. Morgan

BioNTech Is Maintained at Buy by HC Wainwright & Co.

BioNTech price target lowered to $130 from $140 at H.C. Wainwright

Galapagos, Gilead enter pact to collaborate on T cell engager therapies

De.mem Director Restructures Shareholding Without Changing Overall Stake

BRIEF-Galapagos, Gilead Enter Binding Agreement On Ouro Medicines Acquisition

Galapagos, Gilead sign deal tied to Ouro acquisition for T cell engager program

Galapagos Nv - to Fund 50% of $1.675 Bln Upfront and 50% of Milestone Payments for Ouro Deal

THOMSON REUTERS

Galapagos Nv - May Spend $500 Mln Independently, Including up to $150 Mln for Share Repurchases or Dividends

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4568/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1792.3799,"timestamp":1775159999999,"preClose":1791.8947,"halted":0,"volume":88620299,"delay":0,"changeRate":0.000271,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":0.485229,"latestTime":"04-02 16:00:00 EDT","open":1791.5432,"high":1810.8767,"low":1783.7336,"amount":4622629157.710802,"amplitude":0.015148,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1775482200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.526067,"peRate":26.426934,"turnoverRate":0.006401,"increases":7,"decrements":11,"flats":1,"marketCap":1461637100673.75,"floatMarketCap":1441644207575.75},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1810.8767,"amplitude":0.015148,"preClose":1791.8947,"low":1783.7336,"pbRate":"4.526067","latestPrice":1792.3799,"volume":88620299,"delay":0,"open":1791.5432,"prevYearClose":1637.1339,"prevWeekClose":1792.3799,"prevMonthClose":1781.5065,"prevQuarterClose":1781.5065,"fiveDayClose":1737.6821,"twentyDayClose":1786.7603,"sixtyDayClose":1653.1423,"secType":"PLATE","market":"US","turnoverRate":0.006401,"peRate":26.426934,"marketCap":1461637100673.75,"floatMarketCap":1441644207575.75,"timestamp":1775159999999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":7,"down":11,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2624641537","title":"Co-Diagnostics Q4 EPS $(16.65) Down From $(10.82) YoY, Sales $263.922K Up From $149.325K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2624641537","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624641537?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:07","pubTimestamp":1774987655,"startTime":"0","endTime":"0","summary":"Co-Diagnostics (OTC:CODX) reported quarterly losses of $(16.65) per share. This is a 53.88 percent decrease over losses of $(10.82) per share from the same period last year.  The company reported $263.922 thousand in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51583210/co-diagnostics-q4-eps-16-65-down-from-10-82-yoy-sales-263-922k-up-from-149-325k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Co-Diagnostics Q4 EPS $(16.65) Down From $(10.82) YoY, Sales $263.922K Up From $149.325K YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","CODX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624353785","title":"Press Release: Co-Diagnostics Reports Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2624353785","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624353785?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:01","pubTimestamp":1774987260,"startTime":"0","endTime":"0","summary":"Advancing Global Commercialization Strategy Through CoSara and CoMira Joint Ventures. Progressing Clinical Pipeline and Regulatory Pathways for PCR Platform. Strengthening Technology Leadership with AI Integration and Expanding IP Portfolio. SALT LAKE CITY, March 31, 2026 /PRNewswire/ -- Co-Diagnostics, Inc.  , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced its financial results for the full year ended December 31, 2025.-- Revenue of $0.6 million, compared to $3.9 million in 2024, primarily due. -- Operating expenses of $50.6 million, compared to $43.0 million in 2024,driven by a non-cash impairment charge of $18.9 million from revaluation. $37.6 million, or $37.22 per share in 2024, primarily due to intangible. asset impairment charges and lower grant revenue, partially offset by. decreases in operating expenses and a benefit from income taxes. $11.9 million as of December 31, 2025, compared to $29.7 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","CODX","BK4082","BK4604","BK4099","BK4588","BK4022","BK4232","BK4555","03160","BK4568","TM","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624532276","title":"Pomerantz files securities class action against Lakeland Industries, executives in New York court","url":"https://stock-news.laohu8.com/highlight/detail?id=2624532276","media":"Reuters","labels":["executive","policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624532276?lang=en_us&edition=fundamental","pubTime":"2026-04-01 03:51","pubTimestamp":1774986694,"startTime":"0","endTime":"0","summary":"Pomerantz filed securities class action in Southern District of New York against Lakeland Industries, docketed as 26-cv-01501.Suit covers investors who bought Lakeland securities from Dec. 1, 2023 to Dec. 9, 2025.Complaint alleges misleading statements tied to acquisitions of Pacific Helmets, Jolly, citing operational disruptions that undermined performance.Claims cite Sections 10 and 20 of Securities Exchange Act of 1934, citing alleged unreliable guidance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lakeland Industries Inc. published the original content used to generate this news brief on March 31, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL8FhfkX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Pomerantz files securities class action against Lakeland Industries, executives in New York court","news_tag":"executive,policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","IE0031619046.USD","BK4202","IE00B7SZL793.SGD","IE00B66KJ199.SGD","IE00B19Z4B17.USD","LAKE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624531204","title":"Option traders moderately bearish in Moderna with shares up 3.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624531204","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624531204?lang=en_us&edition=fundamental","pubTime":"2026-04-01 01:45","pubTimestamp":1774979114,"startTime":"0","endTime":"0","summary":"Option traders moderately bearish in Moderna (MRNA), with shares up $1.78, or 3.7%, near $50.02. Options volume relatively light with 15k contracts...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/option-traders-moderately-bearish-in-moderna-with-shares-up-3-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/option-traders-moderately-bearish-in-moderna-with-shares-up-3-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4533","MRNA","MRNX","BK4588","MRNY","BK4548","BK4551","BK4501","BK4139","BK4585","BK4568","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623553316","title":"Pfizer Inc Stock (PFE) Moved Up by 3.06% on Mar 31: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2623553316","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623553316?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:16","pubTimestamp":1774970219,"startTime":"0","endTime":"0","summary":"• Pfizer stock rose due to positive clinical trial results.\n• Analyst sentiment is positive, with \"Buy\" ratings and price target increases.\n• Key drug candidates show promise in oncology and infectious disease areas.","market":"fut","thumbnail":"https://resource.tradingkey.com/uploads/20250319/e78e8a798fa24f0a986858933dd647feshutterstock_2452735569.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20250319/e78e8a798fa24f0a986858933dd647feshutterstock_2452735569.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/Market-Movers/261739058-market-movers-pfe-20260331","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0109394709.USD","BK4534","LU0122379950.USD","LU2462157665.USD","LU0456855351.SGD","SG9999015986.USD","LU2237438978.USD","LU2023251221.USD","LU2602419157.SGD","SG9999002232.USD","SG9999014914.USD","LU0114720955.EUR","IE00BN29S564.USD","LU2324357040.USD","IE00B4R5TH58.HKD","IE00BJJMRY28.SGD","LU1093756325.SGD","SG9999014880.SGD","LU1868836914.USD","LU1623119135.USD","LU2361044949.HKD","IE00BFSS7M15.SGD","IE00B2B36J28.USD","LU1061106388.HKD","LU2106854487.HKD","IE00BLSP4452.SGD","SGXZ99366536.SGD","LU2236285917.USD","IE00BFTCPJ56.SGD","IE00BWXC8680.SGD","IE00B1XK9C88.USD","LU0170899867.USD","SG9999014906.USD","LU2491049909.HKD","LU0106261372.USD","LU1814569148.SGD","LU0306807586.USD","LU0234572021.USD","LU1629891620.HKD","LU0225283273.USD","LU0256863902.USD","LU1868837136.USD","LU0708995401.HKD","LU2089283258.USD","SGXZ81514606.USD","SG9999011175.SGD","LU1720051108.HKD","LU2108987350.USD","IE0005OL40V9.USD","LU2461242641.AUD","LU1127390331.HKD","LU2471134879.HKD","IE00B775H168.HKD","IE00BFSS8Q28.SGD","LU0266013472.USD","LU1280957306.USD","LU1989771016.USD","BK4599","BK4592","IE0009355771.USD","LU1974910355.USD","LU2237443382.USD","SGXZ57979304.SGD","LU1232071149.USD","LU2111349929.HKD","SG9999017495.SGD","LU0198837287.USD","LU0321505439.SGD","LU0353189680.USD","LU1988902786.USD","LU1894683264.USD","LU0787776722.HKD","LU0320765992.SGD","LU2456880835.USD","LU2089284900.SGD","LU2491050071.SGD","LU2112291526.USD","LU0820562030.AUD","LU0466842654.USD","LU0964807845.USD","IE00BJT1NW94.SGD","LU2168563687.JPY","LU2168564065.EUR","LU0238689110.USD","SGXZ31699556.SGD","LU1145028129.USD","LU0471298694.HKD","LU2237443895.HKD","LU0882574055.USD","LU1883839398.USD","LU2271345857.HKD","LU1064131342.USD","LU0820561909.HKD","LU0354030438.USD","LU1093756168.USD","LU0109391861.USD","BK4588","IE0004445015.USD","LU1267930730.SGD","LU2168564149.EUR","SG9999018865.SGD","SG9999001176.USD","IE00B4JS1V06.HKD","LU2023250330.USD","LU0256863811.USD","LU0823416689.USD","LU2491050154.USD","IE00BBT3K403.USD","SG9999003800.SGD","BK4533","IE00BKDWB100.SGD","IE00BKPKM429.USD","LU0210536198.USD","LU1366192091.USD","LU0823434583.USD","LU2237443465.HKD","LU2237443978.SGD","IE0002270589.USD","LU2471134523.USD","LU1323610961.USD","LU2552382132.HKD","LU0354030511.USD","LU2756315318.SGD","LU2896262040.SGD","SG9999018857.SGD","BK4007","ELIS","LU2264538146.SGD","LU2552382058.USD","LU2211815571.USD","LU2168564222.USD","LU0943347566.SGD","LU0672654240.SGD","LU1057294990.SGD","LU2063271972.USD","LU2237443622.USD","SG9999001176.SGD","SGXZ51526630.SGD","IE00BK4W5M84.HKD","LU0320765059.SGD","LU0432979614.USD","BK7095","LU2357305700.SGD","IE0001KFT4U8.USD","LU0225771236.USD","LU0079474960.USD","IE00BK4W5L77.USD","IE00B19Z3B42.SGD","GB00BDT5M118.USD","LU2213496289.HKD","LU0786609619.USD","LU1917777945.USD","IE00B7KXQ091.USD","LU1868836591.USD","LU0882574139.USD","LU2417539215.USD","LU1291159041.SGD","LU2746668974.SGD","LU1868836757.USD","LU1804176565.USD","LU1066051498.USD","LU1548497426.USD","IE0004445239.USD","LU0006306889.USD","LU1023059063.AUD","BK4581","LU0323591593.USD","LU0820561818.USD","LU2361044865.SGD","BK4505","LU2361045086.USD","SG9999002224.SGD","LU0689472784.USD","SG9999015945.SGD","BK4550","LU0203201768.USD","LLII","LU0097036916.USD","LU0061475181.USD","LU0094547139.USD","LU0316494557.USD","LU0471298777.SGD","LU0683600562.USD","LU1983299246.USD","LLYZ","LU2023250504.SGD","LU2087625088.SGD","BK4516","IE000M9KFDE8.USD","LU2265009873.SGD","LU0385154629.USD","LU0158827948.USD","IE0002141913.USD","IE00BLSP4239.USD","LU1720051017.SGD","LU0889565916.HKD","LU2552382215.SGD","SG9999015978.USD","LU1551013425.SGD","IE00B1BXHZ80.USD","LU1551013342.USD","LLYX","LU0353189763.USD","LU1035775433.USD","LU0203202063.USD","LU1712237335.SGD","LU0158827781.USD","LU1066053197.SGD","LU2468319806.SGD","LU2756315664.SGD","BK4568","ELIL","LU0823434740.USD","LU0289739699.SGD","LU0321505868.SGD","LU1868837300.USD","LU1894683348.USD","LU2237443549.SGD","PFE","SG9999014898.SGD","IE00B19Z3581.USD","LU2471134952.CNY","IE00BJJMRZ35.SGD","LU2089984988.USD","LU2750360641.GBP","IE00BJLML261.HKD","LU0417517546.SGD","LU0868494617.USD","IE00BJJMRX11.SGD","LU2746668461.USD","LU0640476718.USD","BK4539","LU2028103732.USD","LU2360106947.USD","BK4585","LU0096364046.USD","LU2168564495.EUR","LU2471134796.USD","BK4139","LU0306806265.USD","SG9999015952.SGD","LU2750360997.AUD","LU1069344957.HKD","BK4535","SG9999013999.USD","LU0225284248.USD","LU0985481810.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623339735","title":"Bearish on Pfizer (PFE) as Big Dividend Fails to Mask the Growth Problem","url":"https://stock-news.laohu8.com/highlight/detail?id=2623339735","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623339735?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:08","pubTimestamp":1774969701,"startTime":"0","endTime":"0","summary":"A big dividend can’t hide the growth problem at Pfizer ($PFE), one of the world’s largest pharmaceutical companies. Pfizer has seen its stock rise ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/bearish-on-pfizer-pfe-as-big-dividend-fails-to-mask-the-growth-problem?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/bearish-on-pfizer-pfe-as-big-dividend-fails-to-mask-the-growth-problem?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","SG9999013999.USD","LU0225771236.USD","LU0058720904.USD","LU0456855351.SGD","LU1057294990.SGD","LU0234572021.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","BK4585","LU1894683348.USD","SG9999001176.SGD","SG9999001176.USD","SG9999003800.SGD","SG9999011175.SGD","LU0225284248.USD","LU1894683264.USD","SG9999002224.SGD","LU0321505439.SGD","SGXZ57979304.SGD","IE00BLSP4452.SGD","LU0122379950.USD","LU0985481810.HKD","SG9999002232.USD","BK4588","IE0002270589.USD","BK4592","LU0306807586.USD","VIG","LU0289739699.SGD","IE00BBT3K403.USD","LU1066051498.USD","LU0306806265.USD","BK4534","BK4550","BK4599","LU0170899867.USD","BK4581","LU0868494617.USD","BK4568","BK4007","LU1066053197.SGD","IE00B19Z3581.USD","LU1023059063.AUD","LU0321505868.SGD","IE000M9KFDE8.USD","PFE","LU1883839398.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623580969","title":"Gilead Sciences Inc Stock (GILD) Moved Up by 3.62% on Mar 31: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2623580969","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623580969?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:17","pubTimestamp":1774966623,"startTime":"0","endTime":"0","summary":"• Gilead Sciences reported strong earnings, revenue, and increased dividend.\n• Acquisition of Ouro Medicines bolsters inflammation and autoimmune disease portfolio.\n• Analysts maintain positive ratings with an average price target of $157.90.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/Market-Movers/261738770-market-movers-gild-20260331","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ51526630.SGD","IE0001KFT4U8.USD","LU1145028129.USD","LU2237438978.USD","LU1551013425.SGD","SG9999001176.USD","LU1868837300.USD","LU2211815571.USD","BK4535","LU0965508806.USD","BK4534","ELIS","LU0672654240.SGD","BK4585","LU2237443622.USD","LU0456855351.SGD","LU1280957306.USD","IE00BJJMRY28.SGD","BK4516","LU1623119135.USD","IE00BWXC8680.SGD","LU2491050071.SGD","LU0256863811.USD","LU2237443382.USD","LU2023250330.USD","LU2237443465.HKD","LU2471134796.USD","LU2087625088.SGD","LU0965509101.SGD","LU2106854487.HKD","LU2417539215.USD","LU2111349929.HKD","LU2361044865.SGD","SG9999014898.SGD","SG9999014906.USD","LU0238689110.USD","LU2168564065.EUR","LU2271345857.HKD","LU1720051108.HKD","IE00B2B36J28.USD","LU2361044949.HKD","BK4566","GILD","LU1035775433.USD","LU2746668461.USD","LU0079474960.USD","BK4581","IE00B7SZLL34.SGD","LU1674673428.USD","LU1064131342.USD","LU2063271972.USD","LU2028103732.USD","BK4568","LU0320765992.SGD","LU0882574055.USD","BK4505","LU0471298777.SGD","LU1093756325.SGD","LLYX","LU2168563687.JPY","LU2552382215.SGD","LU0122379950.USD","LU2089984988.USD","LU1267930730.SGD","LU2324357040.USD","LU2602419157.SGD","IE00BSNM7G36.USD","BK4588","IE00BJLML261.HKD","LU0861579265.USD","LU0943347566.SGD","LU1323610961.USD","LU1548497426.USD","LU2750360997.AUD","LU2491049909.HKD","SG9999013999.USD","LU2756315664.SGD","LU1934455863.HKD","LU0097036916.USD","LU0787776722.HKD","LU0158827781.USD","LU0823434583.USD","LU0823434740.USD","LU2168564149.EUR","LU2462157665.USD","IE00BFTCPJ56.SGD","LLII","LU0354030511.USD","LU0466842654.USD","LU0683600562.USD","LU0256863902.USD","LU0820561909.HKD","LU0210536198.USD","LU1066051498.USD","LU0353189680.USD","IE00BJJMRZ35.SGD","LU0820562030.AUD","LU0203202063.USD","LU0061475181.USD","LU0823416689.USD","LU0109391861.USD","LU0354030438.USD","LU0203201768.USD","LU1814569148.SGD","LU1778281490.HKD","LU2471134879.HKD","SGXZ31699556.SGD","LU2896262040.SGD","LU1974910355.USD","IE00B19Z3581.USD","LU0432979614.USD","LU0640476718.USD","SGXZ99366536.SGD","LU0198837287.USD","LU1989771016.USD","SG9999017495.SGD","SGXZ57979304.SGD","SG9999015952.SGD","BK4139","LU0234572021.USD","LU1868836757.USD","LU0234570918.USD","LU2108987350.USD","LU2552382132.HKD","IE0004445239.USD","LU1571399168.USD","LU2089284900.SGD","BK4550","LU1629891620.HKD","LU0323591593.USD","LU1712237335.SGD","LU1868836914.USD","LU0114720955.EUR","LU0266013472.USD","LU0882574139.USD","LU1037948541.HKD","IE00B19Z3B42.SGD","IE00BJJMRX11.SGD","LU1037948897.HKD","LU1291159041.SGD","LU2023250504.SGD","LU2023251221.USD","LU0096364046.USD","LU2237443978.SGD","LU1868836591.USD","LU2468319806.SGD","SG9999015978.USD","LU2237443549.SGD","LU2168564495.EUR","LU2236285917.USD","LU1430594728.SGD","BK4533","IE00BKVL7J92.USD","LU0316494557.USD","LU2112291526.USD","LU0225283273.USD","LU2360106947.USD","BK4578","LU2264538146.SGD","BK4532","LU2089283258.USD","IE0009355771.USD","IE0002270589.USD","ELIL","IE00B1BXHZ80.USD","LU1551013342.USD","LU2361045086.USD","LU2237443895.HKD","SG9999015986.USD","IE00B3T34201.USD","SG9999018865.SGD","LU1069344957.HKD","LU1127390331.HKD","LU0158827948.USD","IE00BKDWB100.SGD","LU0109394709.USD","LU2552382058.USD","LU2461242641.AUD","LU2756315318.SGD","LU1720051017.SGD","SG9999014914.USD","LU2168564222.USD","LU2471134523.USD","SG9999014880.SGD","LU1093756168.USD","LLYZ","IE00BFSS8Q28.SGD","IE00B775H168.HKD","LU1232071149.USD","LU2357305700.SGD","LU1917777945.USD","LU2750360641.GBP","LU0006306889.USD","BK4583","IE00BN29S564.USD","LU0889565916.HKD","LU0786609619.USD","LU1366192091.USD","LU0689472784.USD","IE00BK4W5M84.HKD","LU0353189763.USD","LU1066053197.SGD","LU2456880835.USD","LU2471134952.CNY","LU2746668974.SGD","SG9999001176.SGD","IE00BZ1G4Q59.USD","BK4599","LU0106261372.USD","LU0708995401.HKD","LU0385154629.USD","LU0965509010.AUD","IE00B7KXQ091.USD","IE00B4JS1V06.HKD","IE00B4R5TH58.HKD","LU0820561818.USD","LU2491050154.USD","LU1839511570.USD","IE00B1XK9C88.USD","LU2265009873.SGD","IE0002141913.USD","IE0005OL40V9.USD","LU1804176565.USD","LU1868837136.USD","LU1934455194.USD","LU0058720904.USD","IE00BJT1NW94.SGD","SG9999018857.SGD","IE00BFSS7M15.SGD","LU0417517546.SGD","LU1585245621.USD","LU1934455277.USD","LU1988902786.USD","LU0289739699.SGD","GB00BDT5M118.USD","LU1023059063.AUD","LU2087621335.USD","LU1983299246.USD","LU0965509283.SGD","LU1061106388.HKD","LU0320765059.SGD","LU0471298694.HKD","LU1057294990.SGD","LU1674673691.USD","IE0004445015.USD","LU0094547139.USD","IE00BK4W5L77.USD","BK4539","SGXZ81514606.USD","LU2213496289.HKD","BK4007","IE00BKPKM429.USD","LU0964807845.USD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623803185","title":"AstraZeneca Seen as Leader of Next Generation of Biologic Medicines -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2623803185","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623803185?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:09","pubTimestamp":1774966140,"startTime":"0","endTime":"0","summary":"1409 GMT - AstraZeneca is likely to lead in next-generation biologic medicines, a market that could generate at least $100 billion in U.S. revenue by 2045, Bernstein analysts say. Next-gen biologic technologies such as antibody-drug conjugates and bispecific antibodies are expected to expand quickly due to higher efficacy and less toxicity, according to Bernstein. Britain's AstraZeneca started to bet on this in 2019 via partnership with Daiichi Sankyo for antibody-drug conjugate Enhertu to treat cancer, and has invested heavily since then to build an in-house portfolio of next-gen biologics, the analysts say. \"Hence, unlike its competitors, [AstraZeneca] is no longer reliant on economically dilutive partnerships,\" they add. The company's next-gen pipeline could generate global sales of $30 billion in 2045, Bernstein estimates. Shares rise 0.35%. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","IE00B3T34201.USD","LU0109394709.USD","BK4007","LU2237443622.USD","LU0058720904.USD","LU2237443895.HKD","LU0289739699.SGD","LU2456880835.USD","BK4585","LU1829250122.USD","LU2237443382.USD","LU2417539215.USD","LU2462157665.USD","LU0320765992.SGD","LU2237443978.SGD","BK4568","MDCO","LU2236285917.USD","LU2237443465.HKD","BK4588","LU0889565916.HKD","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191587155","title":"Pfizer Submits Migraine Prevention Drug for Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1191587155","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191587155?lang=en_us&edition=fundamental","pubTime":"2026-03-31 21:24","pubTimestamp":1774963490,"startTime":"0","endTime":"0","summary":"On March 31, the website of the Center for Drug Evaluation showed that Pfizer has submitted an application in China for a new indication of its rimegepant orally disintegrating tablet. The proposed...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306806265.USD","SG9999002232.USD","LU1894683348.USD","IE0002270589.USD","SG9999011175.SGD","BK4568","BK4550","SG9999013999.USD","SG9999001176.USD","LU0170899867.USD","LU0234572021.USD","LU0122379950.USD","PFE","SG9999001176.SGD","BK4533","IE000M9KFDE8.USD","SGXZ57979304.SGD","BK4007","LU1057294990.SGD","LU0289739699.SGD","LU0456855351.SGD","LU0985481810.HKD","LU1066053197.SGD","IE00B19Z3581.USD","LU0225771236.USD","SG9999002224.SGD","LU1883839398.USD","LU0868494617.USD","BK4585","LU0306807586.USD","LU1023059063.AUD","IE00BLSP4452.SGD","LU0225284248.USD","LU0321505868.SGD","LU1066051498.USD","BK4534","BK4592","LU0321505439.SGD","LU0058720904.USD","SG9999003800.SGD","BK4581","BK4599","IE00BBT3K403.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","LU1894683264.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623166584","title":"Galapagos Strikes New Gilead Deal to Co-Develop Gamgertamig and Unlock $500 Million for Strategic Moves","url":"https://stock-news.laohu8.com/highlight/detail?id=2623166584","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623166584?lang=en_us&edition=fundamental","pubTime":"2026-03-31 21:01","pubTimestamp":1774962089,"startTime":"0","endTime":"0","summary":"Galapagos ( ($GLPG) ) has shared an update. On March 31, 2026, Galapagos announced a binding framework agreement with Gilead Sciences tied to Gilea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/galapagos-strikes-new-gilead-deal-to-co-develop-gamgertamig-and-unlock-500-million-for-strategic-moves?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/galapagos-strikes-new-gilead-deal-to-co-develop-gamgertamig-and-unlock-500-million-for-strategic-moves?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289739699.SGD","LU0058720904.USD","BK4566","IE0002270589.USD","BK4532","LU1571399168.USD","LU2087621335.USD","IE00B19Z3B42.SGD","SG9999015978.USD","SG9999015952.SGD","LU1037948897.HKD","LU1023059063.AUD","LU1839511570.USD","LU1674673428.USD","LU0889565916.HKD","LU0320765992.SGD","BK4578","LU1934455277.USD","GILD","LU1066051498.USD","IE00BSNM7G36.USD","LU0965509283.SGD","IE00B3T34201.USD","LU0234570918.USD","LU0965509101.SGD","LU2468319806.SGD","LU0965509010.AUD","IE00B19Z3581.USD","LU0882574055.USD","BK4139","LU1430594728.SGD","LU2112291526.USD","LU0965508806.USD","LU0122379950.USD","LU2324357040.USD","LU1934455863.HKD","LU1674673691.USD","BK4583","LU1585245621.USD","IE00B7SZLL34.SGD","LU1061106388.HKD","LU0109394709.USD","IE00BKVL7J92.USD","LU1057294990.SGD","IE00BZ1G4Q59.USD","LU1934455194.USD","LU0114720955.EUR","BK4568","LU0861579265.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623589931","title":"3SBio Announces 2025 Annual Results: Dual Engines of Innovative R&D and Global Collaboration Propel Revenue Past RMB 10 Billion Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2623589931","media":"prnewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623589931?lang=en_us&edition=fundamental","pubTime":"2026-03-31 20:13","pubTimestamp":1774959180,"startTime":"0","endTime":"0","summary":"SHANGHAI, March 31, 2026 /PRNewswire/ -- 3SBio Inc.  today released its 2025 annual results announcement. Fueled by the dual core engines of breakthroughs in innovative R&D and strategic global collaboration, the company delivered a high-quality performance with both quantitative and qualitative growth: annual revenue hit RMB 17.7 billion, a historic breakthrough past the RMB 10 billion mark, representing a 94.3% year-on-year  increase; net profit attributable to shareholders of the parent company reached RMB 8.48 billion, surging 305.8% YoY; adjusted net profit attributable to shareholders of the parent company stood at RMB 8.45 billion, a 264.6% YoY rise. The company's profitability achieved a leap-forward growth, demonstrating robust growth momentum.Under the collaboration agreement, 3SBio granted Pfizer exclusive global development and commercialization rights to SSGJ-707, with the total potential deal value exceeding US$6 billion. The company is also entitled to tiered double-digi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/3sbio-announces-2025-annual-results-dual-engines-of-innovative-rd-and-global-collaboration-propel-revenue-past-rmb-10-billion-milestone-302729335.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","LU0985481810.HKD","LU1066053197.SGD","LU1894683264.USD","SLE","BK4588","CLDT","IBD","ITP","BK4581","LU0225284248.USD","BK7016","BK1161","IE00BLSP4452.SGD","LU1883839398.USD","SG9999003800.SGD","BK4077","BK4592","IE0002270589.USD","IND","SG9999002232.USD","LU0306806265.USD","BK4007","IE00B19Z3B42.SGD","SG9999011175.SGD","LU0170899867.USD","ADA.AU","BK4568","SG9999001176.USD","LU0321505439.SGD","BK7095","BRVO","BK1583","HK0000165453.HKD","SG9999013999.USD","01530","LU0289739699.SGD","BK4599","IE000M9KFDE8.USD","BK4585","BK4218","LU0321505868.SGD","BK4534","SAA","LU0456855351.SGD","BK4181","IND.AU","BK1593","PFE","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623850115","title":"AstraZeneca (AZN) Gets a Buy from J.P. Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2623850115","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623850115?lang=en_us&edition=fundamental","pubTime":"2026-03-31 19:38","pubTimestamp":1774957099,"startTime":"0","endTime":"0","summary":"In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on AstraZeneca, with a price target of £160.00. According to Ti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-gets-a-buy-from-j-p-morgan-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-gets-a-buy-from-j-p-morgan-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2417539215.USD","LU2271345857.HKD","LU0320765646.SGD","LU2347655156.SGD","LU0528227936.USD","LU0109394709.USD","LU2023251221.USD","BK4568","LU2237443549.SGD","LU2237443622.USD","LU2028103732.USD","LU0882574139.USD","LU2462157665.USD","LU2237443978.SGD","LU0234570918.USD","LU2236285917.USD","LU0557290698.USD","LU0158827781.USD","LU0320765992.SGD","LU2089283258.USD","BK4007","LU0158827948.USD","LU1363072403.SGD","LU0289739699.SGD","LU2133065610.SGD","BK4516","LU1791710400.SGD","LU1074936037.SGD","LU1244550577.SGD","LU1791710582.SGD","LU0795875169.SGD","LU0314104364.USD","LU2357305700.SGD","LU2456880835.USD","LU1989772923.USD","LU2089284900.SGD","AZN","LU1829250122.USD","BK4534","LU1732799900.SGD","LU0058720904.USD","BK4581","LU1668664300.SGD","IE00BZ1G4Q59.USD","LU1162221912.USD","LU1244550221.USD","LU1244550494.USD","LU0971096721.USD","LU0006306889.USD","LU0098860793.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623658323","title":"BioNTech Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2623658323","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623658323?lang=en_us&edition=fundamental","pubTime":"2026-03-31 19:09","pubTimestamp":1774955340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BNTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 31, 2026 07:09 ET (11:09 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BNTX","BK4548","BK4585","BK4139","BK4568","BK4588","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623002043","title":"BioNTech price target lowered to $130 from $140 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2623002043","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623002043?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:16","pubTimestamp":1774952185,"startTime":"0","endTime":"0","summary":"H.C. Wainwright lowered the firm’s price target on BioNTech (BNTX) to $130 from $140 and keeps a Buy rating on the shares. The firm says the initia...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biontech-price-target-lowered-to-130-from-140-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biontech-price-target-lowered-to-130-from-140-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4139","BNTX","BK4548","BK4551","BK4588","BK4585","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623307668","title":"Galapagos, Gilead enter pact to collaborate on T cell engager therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2623307668","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623307668?lang=en_us&edition=fundamental","pubTime":"2026-03-31 17:30","pubTimestamp":1774949454,"startTime":"0","endTime":"0","summary":"Galapagos (GLPG) announced that it has entered into a binding agreement with Gilead (GILD) in connection with Gilead’s definitive agreement to acqu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/galapagos-gilead-enter-pact-to-collaborate-on-t-cell-engager-therapies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/galapagos-gilead-enter-pact-to-collaborate-on-t-cell-engager-therapies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4583","LU0882574055.USD","LU0058720904.USD","LU0109394709.USD","LU1571399168.USD","LU2087621335.USD","IE00B7SZLL34.SGD","BK4585","LU0861579265.USD","BK4139","LU1066053197.SGD","LU2468319806.SGD","IE0002270589.USD","LU0114720955.EUR","LU2089984988.USD","LU1934455194.USD","LU2324357040.USD","LU1037948541.HKD","LU0823416689.USD","BK4578","BK4568","LU1934455863.HKD","LU0234570918.USD","LU0320765992.SGD","SG9999015986.USD","IE00B3T34201.USD","LU0965509101.SGD","IE00BSNM7G36.USD","LU1674673428.USD","SG9999015952.SGD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU1057294990.SGD","SG9999015978.USD","LU0889565916.HKD","LU1934455277.USD","BK4532","GILD","GLPG","LU0122379950.USD","SG9999015945.SGD","LU0965509010.AUD","LU1037948897.HKD","BK4550","LU1430594728.SGD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU1023059063.AUD","LU1066051498.USD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623308499","title":"De.mem Director Restructures Shareholding Without Changing Overall Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2623308499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623308499?lang=en_us&edition=fundamental","pubTime":"2026-03-31 13:49","pubTimestamp":1774936165,"startTime":"0","endTime":"0","summary":"De.mem Ltd. ( ($AU:DEM) ) has provided an update. De.mem Limited has reported a change in the way director Andreas Hendrik De Wit holds his interes...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/de-mem-director-restructures-shareholding-without-changing-overall-stake?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/de-mem-director-restructures-shareholding-without-changing-overall-stake?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","BNTX","BK4588","BK4551","BK4548","BK4585","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623370646","title":"BRIEF-Galapagos, Gilead Enter Binding Agreement On Ouro Medicines Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2623370646","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623370646?lang=en_us&edition=fundamental","pubTime":"2026-03-31 13:32","pubTimestamp":1774935168,"startTime":"0","endTime":"0","summary":"BRIEF-Galapagos, Gilead Enter Binding Agreement On Ouro Medicines AcquisitionMarch 31 (Reuters) - Gilead Sciences Inc GILD.O:ENTERS BINDING AGREEMENT WITH GILEAD ON OURO MEDICINES ACQUISITIONGALAPAGOS","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J0JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU0058720904.USD","LU1839511570.USD","LU2324357040.USD","IE00BKVL7J92.USD","LU0320765992.SGD","LU1057294990.SGD","LU1037948897.HKD","LU0965509010.AUD","SG9999015986.USD","BK4588","LU1066051498.USD","LU1674673691.USD","LU0823416689.USD","LU0114720955.EUR","LU0882574055.USD","LU0965509101.SGD","BK4566","IE00B19Z3B42.SGD","LU1571399168.USD","LU2112291526.USD","LU1674673428.USD","LU1023059063.AUD","BK4583","LU2468319806.SGD","SG9999015952.SGD","LU1061106388.HKD","LU0122379950.USD","LU1934455194.USD","LU2089984988.USD","IE00B7SZLL34.SGD","IE00B19Z3581.USD","LU1778281490.HKD","LU1934455863.HKD","LU0965509283.SGD","BK4568","LU0861579265.USD","GILD","BK4532","LU0109394709.USD","LU1037948541.HKD","LU1066053197.SGD","BK4550","LU0965508806.USD","LU0289739699.SGD","LU1585245621.USD","LU1934455277.USD","SG9999015978.USD","IE00B3T34201.USD","BK4578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623370612","title":"Galapagos, Gilead sign deal tied to Ouro acquisition for T cell engager program","url":"https://stock-news.laohu8.com/highlight/detail?id=2623370612","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623370612?lang=en_us&edition=fundamental","pubTime":"2026-03-31 13:32","pubTimestamp":1774935138,"startTime":"0","endTime":"0","summary":"Galapagos entered binding framework with Gilead tied to Gilead acquisition of Ouro Medicines for USD 1.7 billion upfront, with up to USD 500 million in milestones.Transaction gives Galapagos 50% economic share of acquisition consideration, including substantially all Ouro operating assets such as facilities and personnel.Licenses cover Ouro IP including lead autoimmune program gamgertamig, with Galapagos also gaining rights to additional preclinical autoimmune programs.Commercialization of gamgertamig would be led by Gilead outside KeyMed territories, with Galapagos set to receive 20%-23% tiered royalties on net sales.Agreement also waives restrictions to let Galapagos deploy at least USD 500 million of cash independently, including up to USD 150 million for share buybacks or other distributions.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL6zZ8mX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","LU0889565916.HKD","SG9999014005.SGD","BK4550","IE00B64PRP62.GBP","BK4588","IE00BSNM7G36.USD","LU0861579265.USD","LU0114720955.EUR","BK4139","LU1934455863.HKD","LU1066053197.SGD","LU1037948541.HKD","LU1037948897.HKD","LU2095319765.USD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","BK4585","IE00BN0W2W23.USD","IE00BGHQF748.EUR","LU2468319806.SGD","LU0965509010.AUD","LU2210149790.SGD","LU1839511570.USD","LU1430594728.SGD","IE00BKVL7J92.USD","BK4112","LU1066051498.USD","NDAQ","BK4578","LU0058720904.USD","LU0965509101.SGD","IE0002270589.USD","LU0823416689.USD","SG9999014021.USD","LU0965509283.SGD","SG9999015986.USD","SG9999014039.USD","SG9999014013.SGD","LU1057294990.SGD","GILD","BK4566","LU1674673691.USD","IE00B7SZLL34.SGD","LU1674673428.USD","BK4568","LU0320765992.SGD","LU0882574055.USD","SG9999015952.SGD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623370653","title":"Galapagos Nv - to Fund 50% of $1.675 Bln Upfront and 50% of Milestone Payments for Ouro Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2623370653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623370653?lang=en_us&edition=fundamental","pubTime":"2026-03-31 13:30","pubTimestamp":1774935013,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J0JK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0234570918.USD","LU0320765992.SGD","BK4588","BK4568","LU0122379950.USD","IE00B3T34201.USD","BK4139","LU2468319806.SGD","BK4578","GILD","LU0965509101.SGD","LU0882574055.USD","IE00BSNM7G36.USD","LU1430594728.SGD","LU2089984988.USD","LU1037948541.HKD","IE0002270589.USD","LU1571399168.USD","LU0289739699.SGD","LU1066053197.SGD","LU1674673691.USD","LU0861579265.USD","LU1934455277.USD","LU0823416689.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","BK4585","LU0114720955.EUR","LU0889565916.HKD","SG9999015986.USD","LU0965509010.AUD","LU1778281490.HKD","LU1023059063.AUD","LU0965508806.USD","LU1839511570.USD","BK4532","BK4566","LU2324357040.USD","LU1061106388.HKD","IE00B7SZLL34.SGD","LU0965509283.SGD","LU1934455863.HKD","SG9999015945.SGD","LU2087621335.USD","IE00B19Z3B42.SGD","LU1057294990.SGD","IE00B19Z3581.USD","LU1037948897.HKD","SG9999015952.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623370652","title":"Galapagos Nv - May Spend $500 Mln Independently, Including up to $150 Mln for Share Repurchases or Dividends","url":"https://stock-news.laohu8.com/highlight/detail?id=2623370652","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623370652?lang=en_us&edition=fundamental","pubTime":"2026-03-31 13:30","pubTimestamp":1774935013,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J0JK:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1430594728.SGD","LU1037948541.HKD","LU2112291526.USD","LU1066053197.SGD","BK4588","LU1571399168.USD","LU1839511570.USD","SG9999015986.USD","LU0889565916.HKD","LU1057294990.SGD","LU1023059063.AUD","IE00B7SZLL34.SGD","LU0965509101.SGD","LU2468319806.SGD","LU0114720955.EUR","LU1585245621.USD","BK4532","LU0965508806.USD","LU0965509010.AUD","BK4578","IE0002270589.USD","SG9999015978.USD","LU2089984988.USD","BK4566","SG9999015945.SGD","SG9999015952.SGD","LU0823416689.USD","IE00B19Z3B42.SGD","LU1934455277.USD","LU1037948897.HKD","GILD","LU2324357040.USD","LU0234570918.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","BK4568","LU0058720904.USD","LU0109394709.USD","LU1674673691.USD","IE00B3T34201.USD","IE00BSNM7G36.USD","BK4139","BK4550","IE00BKVL7J92.USD","LU1934455194.USD","LU0289739699.SGD","LU1778281490.HKD","LU2087621335.USD","LU0861579265.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":6,"totalSize":318,"code":"91000000","status":"200"}]}}